Epidemiology of falls.
T Masud, R O Morris
https://pubmed.ncbi.nlm.nih.gov/11769786Actively Recruiting
Led by McGill University Health Centre/Research Institute of the McGill University Health Centre · Updated on 2024-07-12
100
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating a personalized video-based exercise program called SAFE to help prevent falls in frail and pre-frail older adults aged 75 and over. This randomized trial will compare participants who follow the SAFE exercise program with those who continue their usual daily activities without adding the exercises. The study aims to assess changes in muscular strength, functional abilities, cognitive function, and quality of life over 12 weeks. Participants in the experimental group will perform the SAFE exercises three times a week for 12 weeks at home with caregiver support. Healthcare professionals will visit during the first week to teach the exercises using video capsules available online, which include four levels of difficulty and five categories: warm-up, strength, balance, flexibility, and endurance. The control group will maintain their usual activities without changes. After the intervention, the experimental group is encouraged to continue the exercises, while the control group can choose to start them. A follow-up telephone call will occur 12 weeks after the intervention to check ongoing exercise participation. Participants will have four visits: a screening visit, a pre-intervention assessment of cognition and function, a virtual follow-up call, and a post-intervention assessment. Assessments will measure muscle strength, functional capacity, cognitive abilities, and quality of life before and after the 12-week program. Researchers will monitor adherence and collect data to evaluate the program's impact on fall prevention and physical and cognitive health. The total participation includes the intervention and a 12-week post-intervention follow-up.
CONDITIONS
A Personalized Video-based Exercise Program for Fall Prevention in Frail and Pre-frail Older Adult
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) at participant's residence
Duration - 1 week
Participants complete assessments of cognition and functional abilities and receive an explanation of the exercise program.
1 visit (in-person) at participant's residence
Duration - 12 weeks
Participants in the experimental group perform the SAFE exercise program three times a week for 12 weeks at home. Control group participants maintain their usual activities of daily living without changes.
1 virtual visit (phone call) during the intervention period
Duration - 1 week
Participants complete assessments of cognition and functional abilities to evaluate changes after the intervention.
1 visit (in-person) at participant's residence
Duration - 12 weeks post-intervention
Participants are contacted by phone 12 weeks after the intervention to check whether they continue the SAFE exercise program.
1 virtual visit (phone call)
Total: 1 location
1
Royal Victoria Hospital - Glen site
Montreal, Quebec, Canada, H4A 3J1
Actively Recruiting
G
Guy Hajj Boutros
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
T Masud, R O Morris
https://pubmed.ncbi.nlm.nih.gov/11769786Tareef Al-Aama
https://pubmed.ncbi.nlm.nih.gov/21753098Laurence Z Rubenstein
https://pubmed.ncbi.nlm.nih.gov/16926202Catherine Sherrington, Anne Tiedemann, Nicola Fairhall...
https://pubmed.ncbi.nlm.nih.gov/21632004L P Fried, C M Tangen, J Walston...
https://pubmed.ncbi.nlm.nih.gov/11253156Ziad S Nasreddine, Natalie A Phillips, Valérie Bédirian...
https://pubmed.ncbi.nlm.nih.gov/15817019Tom N Tombaugh
https://pubmed.ncbi.nlm.nih.gov/15010086A R Jensen, W D Rohwer
https://pubmed.ncbi.nlm.nih.gov/5328883